ZINLISTIQ Trademark

Trademark Overview

On Friday, March 1, 2013, a trademark application was filed for ZINLISTIQ with the United States Patent and Trademark Office. The USPTO has given the ZINLISTIQ trademark a serial number of 85864154. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2017. This trademark is owned by Eli Lilly and Company. The ZINLISTIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric d...
zinlistiq

General Information

Serial Number85864154
Word MarkZINLISTIQ
Filing DateFriday, March 1, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders; sleep disorders and urological disorders; antidepressants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 7, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, May 15, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 15, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 29, 2016EXTENSION 5 GRANTED
Friday, September 23, 2016EXTENSION 5 FILED
Friday, September 23, 2016TEAS EXTENSION RECEIVED
Tuesday, February 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 22, 2016EXTENSION 4 GRANTED
Tuesday, January 26, 2016EXTENSION 4 FILED
Tuesday, January 26, 2016TEAS EXTENSION RECEIVED
Wednesday, September 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 29, 2015EXTENSION 3 GRANTED
Friday, September 25, 2015EXTENSION 3 FILED
Friday, September 25, 2015TEAS EXTENSION RECEIVED
Thursday, April 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 29, 2015EXTENSION 2 GRANTED
Friday, March 20, 2015EXTENSION 2 FILED
Monday, April 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 20, 2015TEAS EXTENSION RECEIVED
Thursday, September 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 23, 2014EXTENSION 1 GRANTED
Tuesday, September 23, 2014EXTENSION 1 FILED
Tuesday, September 23, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 3, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 2, 2014ASSIGNED TO LIE
Thursday, December 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 5, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 4, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 4, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 13, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2013NON-FINAL ACTION E-MAILED
Thursday, June 13, 2013NON-FINAL ACTION WRITTEN
Thursday, June 13, 2013ASSIGNED TO EXAMINER
Thursday, March 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 5, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

zinlistiq disorders diseases pharmaceutical preparations treatment kidney inflammation inflammatory hormonal gastrointestinal